Markets:

Overview

News

Currencies

International

Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

18.84 -0.07 (-0.37%)

Streaming Delayed Price Updated: 2:56 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Theravance Biopharma, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >

Happy December ↗

December 01, 2021

Inflation levels this year will almost certainly lower growth in 2022 because of inflation this year in everything from house prices....to stock prices.

Via Talk Markets

Theravance Biopharma Pulls Plug On Izencitinib Crohn's Disease Trial ↗

November 16, 2021

Theravance Biopharma Inc (NASDAQ: TBPH) has voluntarily discontinued its Phase 2 study of izencitinib (gut-selective oral pan-JAK inhibitor) in Crohn’s...

Via Benzinga

Veteran's Day ↗

November 11, 2021

Stock markets took a tumble today across the board, but not as far down as at the opening.

Via Talk Markets

Expert Ratings For Theravance Biopharma ↗

November 05, 2021

Within the last quarter, Theravance Biopharma (NASDAQ:TBPH) has observed t...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021 ↗

November 05, 2021

Upgrades For IGM Biosciences Inc (NASDAQ:

Via Benzinga

A Peek Into The Markets: US Stock Futures Mixed; All Eyes On Jobs Report ↗

November 05, 2021

Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the S&P 500 and Nasdaq surged to record highs in the previous session. Investors are awaiting...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 04, 2021

Gainers Evaxion Biotech (NASDAQ:EVAX) shares increased by 244.61% to $22.4 during Thursday's pre-market session. The company's market cap stands at $430.0 million...

Via Benzinga

Theravance Biopharma, inc (TBPH) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

TBPH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

More Chinese Trouble ↗

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

Via Talk Markets

A Bit Of A Recovery ↗

September 29, 2021

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

Via Talk Markets

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

China's Rescue Of Evergrand ↗

September 23, 2021

The number of jobless last week was higher than the forecast, at 351,000 vs 320,000. The recovery is lagging.

Via Talk Markets

Analyst Ratings For Theravance Biopharma ↗

September 16, 2021

Analysts have provided the following ratings for Theravance Biopharma (NASDAQ:T...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

September 16, 2021

Barclays boosted Adobe Inc. (NASDAQ:ADBE) price t...

Via Benzinga

Why Theravance Biopharma Stock Dived 16% Today ↗

September 15, 2021

The biotech is not enjoying a winning streak with its pipeline drugs.

Via The Motley Fool

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 15, 2021

Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...

Via Benzinga

53 Biggest Movers From Yesterday ↗

September 16, 2021

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...

Via Benzinga

Topics Initial Public Offering

Why Are Theravance Bio Shares Plummeting Premarket Today? ↗

September 15, 2021

Theravance Biopharma Inc (NASDAQ: TBPH) will reduce its headcount by approximately 75% (estimated 270 positions), with most of the lay off to complete in November...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 15, 2021

Gainers Indaptus Therapeutics (NASDAQ:INDP) shares increased by 68.88% to $11.94 during Wednesday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 27, 2021

Before 10 a.m. ET on Friday, 29 stocks hit new 52-week lows. Significant Points: Campbell Soup (NYSE:CPB) was the biggest company by market cap to set a new 52-week low....

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021 ↗

August 25, 2021

Upgrades For Kite Realty Group Trust (NYSE:

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 25, 2021

On Wednesday morning, 17 companies hit new 52-week lows. Things to Consider: The largest company by market cap to set a new 52-week low was Campbell Soup (NYSE:CPB...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

August 25, 2021

Wells Fargo raised the price target for Urban Outfitters, Inc. (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug ↗

August 25, 2021

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.